The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mathematical predication models to optimize post-treatment surveillance in HPV-associated oropharyngeal cancer.
 
Vivek Nair
No Relationships to Disclose
 
Samuel Auger
No Relationships to Disclose
 
Sara Kochanny
No Relationships to Disclose
 
Frederick Howard
No Relationships to Disclose
 
Daniel Ginat
No Relationships to Disclose
 
Olga Pasternak-Wise
No Relationships to Disclose
 
Aditya Juloori
No Relationships to Disclose
 
Evgeny Izumchenko
No Relationships to Disclose
 
Nishant Agrawal
No Relationships to Disclose
 
Ari Rosenberg
Consulting or Advisory Role - EMD Serono; Nanobiotix
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals
Honoraria - Abbvie; Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Takeda (I)
Consulting or Advisory Role - Abbvie; Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Takeda (I)
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Lilly (Inst); Novartis
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis
 
Reza Skandari
No Relationships to Disclose
 
Alexander T. Pearson
Stock and Other Ownership Interests - Inovalon (I)
Consulting or Advisory Role - Prelude Therapeutics